Chronic Kidney Disease (CKD)
Also known as: Chronic Kidney Disease / Chronic Kidney Disease(CKD) / Kidney Diseases, Chronic / Kidney Disease, Chronic / Chronic Kidney Diseases / Chronic Kidneys Disease / Chronic renal disease
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06723 | Aluminum hydroxide | An antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach. |
| DB06724 | Calcium carbonate | An ionic compound used as a calcium supplement or antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach. |
| DB01012 | Cinacalcet | A calcium sensing receptor agonist used to treat secondary hyperparathyroidism in chronic kidney disease and hypercalcemia in parathyroid carcinoma. |
| DB00012 | Darbepoetin alfa | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. |
| DB00016 | Erythropoietin | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. |
| DB12865 | Etelcalcetide | A calcium sensing receptor agonist used to treat secondary hyperparathyroidism in patients with chronic kidney disease who require hemodialysis. |
| DB13995 | Ferric pyrophosphate citrate | A soluble iron compound used to maintain hemoglobin levels in patients undergoing hemodialysis. |
| DB06215 | Ferumoxytol | An intravenous iron replacement product used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), or in patients who are unable to tolerate or who have not responded adequately to oral iron supplementation. |
| DB16165 | Finerenone | A nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes. |
| DB01592 | Iron | An essential element commonly used for the treatment of patients with documented iron deficiency. |
| DB09107 | Methoxy polyethylene glycol-epoetin beta | A synthetic erythropoiesis stimulating agent (ESA) used to treat anemia associated with chronic kidney disease. |
| DB09517 | Sodium ferric gluconate complex | An iron complex used for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. |
| DB00052 | Somatotropin | A recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults. |
| DB14520 | Tetraferric tricitrate decahydrate | A phosphate binder used to control serum phosphorus levels or as an iron supplement. |